Cannabix Technologies Files THC Based Ignition Interlock Patent Application and Provides Update on Marijuana Breathalyzer Dev...
November 07 2017 - 8:00AM
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company
or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for
law enforcement and the workplace, is pleased to report that it has
filed several Patent Cooperation Treaty (“PCT”) applications
related to product development innovations over the last several
months. Some of the PCT applications are for a marijuana focused
Ignition Interlock device. An Ignition Interlock Device
(“IID”) requires a driver to blow into an installed device
confirming the driver is not impaired before the vehicle will
start. Many countries are requiring an IID as a condition for
drivers convicted of driving under the influence of alcohol and
drugs, especially repeat offenders.
Courts typically mandate drivers who have received
multiple alcohol impaired driving convictions to install IIDs and
drivers are required to provide a breath sample before a vehicle
can be started, in addition to intermittent re-sampling during
longer trips. In the U.S. and Canada, most states and
provinces have approved some form of IID use. Additionally,
families are voluntarily choosing to install ignition interlock
systems in their vehicles to help guard against new or young
drivers from driving under the influence of alcohol and drugs.
The Company is also pleased to report development of its “Beta
3.0” (Cannabix Marijuana Breathalyzer) device based on its FAIMS-
(field asymmetric waveform ion mobility spectrometry) is 95%
complete and the company will commence testing with this latest
device shortly. The Company has ramped up development efforts with
its Beta devices and has made several technological improvements
for field use. These include adding a feedback loop to the
dielectric barrier discharge (“DBD”) ion source which allows a
shorter time to stable ionization with a conventional battery
source resulting in a quicker start-up time. Furthermore, a
specialized breath temperature stabilizing component, that
maintains consistent breath temperature in cold as well as humid
temperature settings, has been tested and is performing well. The
device includes a new and improved, low power highly sensitive
“detector” component.
CEO Rav Mlait states, “Cannabix Technologies continues to
receive considerable interest from government and law enforcement
for the development of its point of care Cannabix Marijuana
Breathalyzer. Our team of scientists in Vancouver and Florida are
working methodically and rapidly to develop this device for the
public. We are excited to have made applications to initiate IP
protection of our marijuana focussed Ignition Interlock
system.”
About Cannabix Technologies Inc
Cannabix Technologies Inc. is a leader in marijuana breathalyzer
development for law enforcement and the workplace. Cannabix has
established breath testing technologies in the pursuit of bringing
durable, portable hand-held tools to market to enhance detection of
marijuana impaired driving offences on roads at a time when
marijuana is becoming legal in many global jurisdictions. Cannabix
is working to develop drug-testing devices that will detect THC-
the psychoactive component of marijuana that causes intoxication-
using breath samples. In particular, Cannabix is focused on
developing breath testing devices for detection of recent use of
THC, in contrast to urine testing for THC metabolite that requires
an invasive collection and reflects use days or even weeks earlier.
The devices will also be useful for other practical applications
such as testing employees in the workplace where intoxication by
THC can be hazardous.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEOCannabix Technologies Inc.
For further information, contact the Company at
info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking information that
involves various risks and uncertainties regarding future events.
Such forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company’s plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing “patent pending” technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
Cannabix Technologies Inc.7934 Government Road, Burnaby, B.C.,
V5A 2E2Phone: (604) 551-7831Fax:
604-676-2767info@cannabixtechnologies.comcannabixtechnologies.com
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Apr 2023 to Apr 2024